B of A Securities raises Humana price target to $380

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

B of A Securities analyst Kevin Fischbeck maintained a Neutral rating on Humana (NYSE: HUM) and raised the price target to $380 from $340.

powered bylight_fuzz_icon
43868342

*this image is generated using AI for illustrative purposes only.

B of A Securities analyst Kevin Fischbeck has maintained a Neutral rating on Humana (NYSE: HUM) and increased the price target to $380 from $340. The adjustment reflects a revised valuation outlook for the healthcare company.

The revised target suggests a potential upside based on the previous closing price, though the firm remains cautious on the stock's near-term trajectory. The Neutral stance indicates that the stock is expected to perform in line with the broader market.

Metric Value
Rating Neutral
Previous Price Target $340
New Price Target $380

Investors will monitor Humana's upcoming earnings and operational updates to gauge if the company can meet the revised expectations set by B of A Securities.

What specific operational factors could drive Humana's stock to meet the new $380 price target?

How might upcoming earnings reports influence B of A Securities' Neutral rating?

What risks could prevent Humana from achieving the revised valuation outlook?

like19
dislike

Humana to release Q2 2026 results on July 29, 2026

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Humana Inc. will announce its Q2 2026 financial results on July 29, 2026, followed by a live Q&A session. The earnings release will include non-GAAP financial measures with a reconciliation to GAAP. Participants can register in advance for the call, and a webcast archive will be available later.

powered bylight_fuzz_icon
43707846

*this image is generated using AI for illustrative purposes only.

Humana Inc. will release its financial results for the second quarter of 2026 (2Q26) on July 29, 2026, at 6:00 a.m. Eastern time. The company will also provide prepared management remarks in PDF format. A live question-and-answer session is scheduled for 8:00 a.m. Eastern time the same day to discuss the quarterly results and earnings guidance for 2026.

The 2Q26 earnings call webcast will be accessible via Humana’s Investor Relations page at https://humana.gcs-web.com/ . Participants wishing to ask questions during the session must register in advance at https://register-conf.media-server.com/register/BI18085d824058461aa3c6b8b2af27cb40 . Upon registration, telephone participants will receive a confirmation email with dial-in details and a unique registrant ID.

Humana advises participants to sign in or dial in at least 15 minutes before the call. For those unable to attend the live event, a virtual presentation archive will be available approximately two hours after the webcast in the Historical Webcasts and Presentations section of the Investor Relations page.

The company’s 2Q26 earnings news release will include financial measures not in accordance with Generally Accepted Accounting Principles (GAAP). A reconciliation of these non-GAAP measures to GAAP results, along with management’s rationale for their inclusion, will be provided in the release and available on the Investor Relations page at www.humana.com on July 29, 2026.

Key Event Details

Event Date Time (Eastern)
Financial Results Release July 29, 2026 6:00 a.m.
Live Q&A Session July 29, 2026 8:00 a.m.
Webcast Archive Availability July 29, 2026 ~2 hours post-webcast

Humana is a leading U.S. healthcare company providing insurance services through Humana and healthcare services through CenterWell. The company serves millions of individuals, including those with Medicare and Medicaid, military personnel, and communities at large.

How might the 2Q26 earnings results influence Humana's strategic priorities for the remainder of 2026?

What potential market reactions could investors expect following the release of non-GAAP financial measures?

Could the earnings guidance for 2026 signal shifts in Humana's approach to Medicare and Medicaid services?

like18
dislike

More News on Humana Inc